‘They won't do any harm and might do some good’: time to think again on the use of antidepressants?
Open accessThe DOI matches its Crossref record; 16 of the 17 references it cites were found in a registry or an index.
Abstract
Despite NICE guidance that should have limited it, antidepressant prescribing continues to increase. Research evidence suggests that much if not all of the observed efficacy should be attributed to complex non-specific effects rather than 'restoration of disturbed brain chemistry'. According to this view the uncertain benefits of antidepressants are unlikely to outweigh the risks, suggesting the need to explore other approaches to treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Minimisation of these methodological flaws has led to antidepressants being presented as more effective than is warranted by existing data.20,38,42,43”
From The ‘patient voice’: patients who experience antidepressant withdrawal symptoms are often dismissed, or misdiagnosed with relapse, or a new medical condition (2020) · cites this paper as [42]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“As a consequence of the minimisation of their withdrawal effects, as well as a number of their other side effects (perhaps reflected in the infrequency with which GPs discuss these issues with patients), antidepressants have also been regarded as more safe that is warranted by existing data.42–45”
From The ‘patient voice’: patients who experience antidepressant withdrawal symptoms are often dismissed, or misdiagnosed with relapse, or a new medical condition (2020) · cites this paper as [42]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kirsch, I., Deacon, B. J., Huedo-Medina, T. B., Scoboria, A., Moore, T. J., & Johnson, B. T. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050045 · Cited by 2,442 · cited 1×
“The association between rising levels of drug treatment and increasing disability may not be surprising in the light of recent research on antidepressants which suggests they may not be superior to placebo, certainly for the majority of patients with milder degrees of depression.(8,9) Even for those with more severe d…”
ResultAntidepressant Drug Effects and Depression Severity: A Patient-Level Meta-analysis
Fournier, J. C., DeRubeis, R. J., Hollon, S. D., Dimidjian, S., Amsterdam, J. D., Shelton, R. C., & Fawcett, J. (2010) · JAMA · doi:10.1001/jama.2009.1943 · Cited by 2,009 · cited 1×
“The association between rising levels of drug treatment and increasing disability may not be surprising in the light of recent research on antidepressants which suggests they may not be superior to placebo, certainly for the majority of patients with milder degrees of depression.(8,9) Even for those with more severe d…”
ResultComponents of placebo effect: randomised controlled trial in patients with irritable bowel syndrome
Kaptchuk, T. J., Kelley, J. M., Conboy, L. A., Davis, R. B., Kerr, C. E., Jacobson, E. E., Kirsch, I., Schyner, R. N., Nam, B. H., Nguyen, L. T., et al. (2008) · BMJ · doi:10.1136/bmj.39524.439618.25 · Cited by 1,196 · cited 1×
“Where the placebo effect has been studied in detail it appears to involve three core components; acknowledgment of the patient’s difficulties by paying attention to the problem, a credible therapeutic ritual, and the quality of the patient–practitioner relationship.(18)”
BackgroundEmotional side-effects of selective serotonin reuptake inhibitors: qualitative study
Price, J., Cole, V., & Goodwin, G. M. (2009) · British Journal of Psychiatry · doi:10.1192/bjp.bp.108.051110 · Cited by 362
The myth of the chemical cure: a critique of psychiatric drug treatment
(2008) · Choice Reviews Online · doi:10.5860/choice.45-7074 · Cited by 277
Goldberg, D. P., Privett, M., Ustun, B., Simon, G., & Linden, M. (1998) · Europe PMC (PubMed Central) · Cited by 182
Efficacy of antidepressants: a re-analysis and re-interpretation of the Kirsch data
Fountoulakis, K. N., & Möller, H.-J. (2011) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145710000957 · Cited by 140
Double, D. (2002) · BMJ · doi:10.1136/bmj.324.7342.900 · Cited by 130
Do Antidepressants Cure or Create Abnormal Brain States?
Moncrieff, J., & Cohen, D. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030240 · Cited by 97 · cited 2×
“The fact that psychoactive substances not normally considered to be antidepressants, including antipsychotics, stimulants, and benzodiazepines have similar effects to antidepressants in some trials, and that antidepressants themselves come from diverse chemical classes, supports the idea that it is the psychoactive an…”
BackgroundSelf-citationKirsch, I., Moore, T. J., Scoboria, A., & Nicholls, S. S. (2002) · Prevention & Treatment · doi:10.1037//1522-3736.5.0023a · Cited by 68
Long-term prescribing of antidepressants in the older population: a qualitative study
Dickinson, R., Knapp, P., House, A. O., Dimri, V., Zermansky, A., Petty, D., Holmes, J., & Raynor, D. K. (2010) · British Journal of General Practice · doi:10.3399/bjgp10x483913 · Cited by 66
How do psychiatric drugs work?
Moncrieff, J., & Cohen, D. (2009) · BMJ · doi:10.1136/bmj.b1963 · Cited by 65
Self-citationLasserre, A., Younès, N., Blanchon, T., Cantegreil-Kallen, I., Passerieux, C., Thomas, G., Chan-Chee, C., & Hanslik, T. (2010) · British Journal of General Practice · doi:10.3399/bjgp10x483922 · Cited by 60
Symptom Severity and Exclusion From Antidepressant Efficacy Trials
Zimmerman, M., Posternak, M. A., & Chelminski, I. (2002) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200212000-00011 · Cited by 49 · cited 1×
“In any event, in a recent survey, 71% of ‘depressed’ treatment-seeking outpatients had a HDRS score <22.(11) Every day thousands of prescriptions for antidepressants are written without any likelihood that their effects will differ from placebo, with considerable implications for avoidable harm and opportunities for f…”
BackgroundSiriwardena, A. N. (2010) · British Journal of General Practice · doi:10.3399/bjgp10x483878 · Cited by 9
Patel, K. (2009) · BMJ · doi:10.1136/bmj.b1535 · Cited by 3
Cited by
Mojtabai, R. (2013) · Psychotherapy and Psychosomatics · doi:10.1159/000345968 · Cited by 101
Guy, A., Brown, M., Lewis, S., & Horowitz, M. (2020) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125320967183 · Cited by 77
An analysis of antidepressant prescribing trends in England 2015–2019.
Lalji, H. M., McGrogan, A., & Bailey, S. (2021) · Journal of Affective Disorders Reports · doi:10.1016/j.jadr.2021.100205 · Cited by 74
Lin, Y.-H., Sahker, E., Shinohara, K., Horinouchi, N., Ito, M., Lelliott, M., Cipriani, A., Tomlinson, A., Baethge, C., & Furukawa, T. A. (2022) · EClinicalMedicine · doi:10.1016/j.eclinm.2022.101505 · Cited by 56
Kimball, S., Mirhosseini, N. Z., & Rucklidge, J. J. (2018) · Nutrients · doi:10.3390/nu10020152 · Cited by 51
Metadata
- Authors
- Middleton, H., & Moncrieff, J.
- Affiliations
- University of Nottingham (GB)
- ORCID
- Moncrieff, Joanna
- Venue
- British Journal of General Practice
- Published
- 2011-01-01
- Volume
- 61
- Issue
- 582
- Pages
- 47-49
- ISSN
- 0960-1643 (ISSN-L)
- 1478-5242
- PMC
- PMC3020050
- OpenAlex
- W2102660516
- Cited by
- 36
- References
- 17
- Citations by year
- 2024: 2 · 2023: 1 · 2022: 2 · 2021: 2 · 2020: 2 · 2019: 1 · 2018: 3 · 2017: 2 · 2016: 2 · 2015: 4 · 2014: 1 · 2013: 7 · 2012: 3
- FWCI
- 3.51
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- British Journal of General Practice (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Social Sciences › Psychology › Clinical Psychology › Psychotherapy Techniques and Applications
- Keywords
- antidepressants, antidepressant prescribing, NICE guidelines, non-specific effects, placebo response, antidepressant efficacy, depression treatment, alternative treatment
- MeSH terms
- Antidepressive Agents, Depressive Disorder, Humans, Practice Patterns, Physicians'
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.